microDimensions GmbH, a Munich, Germany-based software and service provider for digital pathology that specializes in automated image analysis, raised a seven-digit Series A financing round.
The round was led by business angel Dr. Adriaan Hart de Ruijter with participation from High-Tech Gründerfonds, Bayern Kapital and a group of business angels.
The company intends to use the funds to further extend its product portfolio for biomarker image analysis.
Led by Dr. Martin Groher, CEO, microDimensions has developed image processing technology that can speed up and automate workflows in (pre-)clinical drug development studies and clinical diagnosis. Besides its standardized software solutions, the company offers the development of custom applications as well as a range of image analysis services.
microDimensions serves major pharma, biotech, and medtech players, and various university pathology departments.